LONG-TERM EFFECTS OF ANTI-VEGF MONOTHERAPY FOR RETINOPATHY OF PREMATURITY ON THE RETINAL AND REFRACTIVE DEVELOPMENT OF EYE
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, cilt.42, sa.11, ss.2194-2202, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 42 Sayı: 11
- Basım Tarihi: 2022
- Doi Numarası: 10.1097/iae.0000000000003590
- Dergi Adı: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, MEDLINE
- Sayfa Sayıları: ss.2194-2202
- Anahtar Kelimeler: retinopathy of prematurity, anti-VEGF, ranibizumab, aflibercept, bevacizumab, fundus fluorescein angiography, refractive, spectral domain optical coherence tomography, ENDOTHELIAL GROWTH-FACTOR, INTRAVITREAL BEVACIZUMAB, TYPE-1 RETINOPATHY, OCULAR GROWTH
- Gazi Üniversitesi Adresli: Evet
Özet
Purpose: To evaluate vascular maturation of retina, axial, refractive, and foveal development after anti-VEGF treatment including bevacizumab, ranibizumab, and aflibercept in infants with treatment requiring retinopathy of prematurity (ROP) in long term.